1. A comprehensive understanding of lowly-hydrolyzed polyvinyl alcohol-based ternary solid dispersions with the use of a combined mixture-process design. (3rd October 2019) Authors: Mori, Yoshimasa; Higashi, Taishi; Motoyama, Keiichi; Ishida, Makoto; Onodera, Risako; Arima, Hidetoshi Journal: Drug development and industrial pharmacy Issue: Volume 45:Number 10(2019) Page Start: 1599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model. Issue 9 (20th August 2021) Authors: Suzuki, Yusuke; Hayashi, Tomoya; Yokoyama, Ryoma; Nakagawa, Fumika; Inoue, Joe; Higashi, Taishi; Onodera, Risako; Motoyama, Keiichi Journal: FEBS open bio Issue: Volume 11:Issue 9(2021) Page Start: 2619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mannose-methyl-β-cyclodextrin suppresses tumor growth by targeting both colon cancer cells and tumor-associated macrophages. (1st April 2023) Authors: Ohno, Yoshitaka; Toshino, Maiko; Mohammed, Ahmed F.A.; Fujiwara, Yukio; Komohara, Yoshihiro; Onodera, Risako; Higashi, Taishi; Motoyama, Keiichi Journal: Carbohydrate polymers Issue: Volume 305(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nanoparticles of folic acid‐methyl‐β‐cyclodextrin (FA‐MβCD)/adamantane‐albumin exhibit enhanced antitumor activity compared with FA‐MβCD alone. Issue 2 (26th December 2022) Authors: Sakai, Aiko; Yamashita, Yuki; Misumi, Shogo; Kishimoto, Naoki; Onodera, Risako; Higashi, Taishi; Arima, Hidetoshi; Motoyama, Keiichi Journal: FEBS open bio Issue: Volume 13:Issue 2(2023) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Polypseudorotaxane-based supramolecular hydrogels consisting of cyclodextrins and Pluronics as stabilizing agents for antibody drugs. (15th March 2021) Authors: Ohshita, Naoko; Motoyama, Keiichi; Iohara, Daisuke; Hirayama, Fumitoshi; Taharabaru, Toru; Watabe, Naoki; Kawabata, Youhei; Onodera, Risako; Higashi, Taishi Journal: Carbohydrate polymers Issue: Volume 256(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Polyrotaxane-based multi-step transformable materials for the delivery of Cas9 ribonucleoprotein. (June 2022) Authors: Taharabaru, Toru; Kihara, Takuya; Onodera, Risako; Kogo, Tetsuya; Higashi, Kenjirou; Moribe, Kunikazu; Nakamura, Teruya; Motoyama, Keiichi; Higashi, Taishi Journal: Applied materials today Issue: Volume 27(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy. (April 2014) Authors: Motoyama, Keiichi; Onodera, Risako; Okamatsu, Ayaka; Higashi, Taishi; Kariya, Ryusho; Okada, Seiji; Arima, Hidetoshi Journal: Journal of drug targeting Issue: Volume 22:Number 3(2014) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Supramolecular polymer-based transformable material for reversible PEGylation of protein drugs. (September 2021) Authors: Utatsu, Kosei; Kogo, Tetsuya; Taharabaru, Toru; Onodera, Risako; Motoyama, Keiichi; Higashi, Taishi Journal: Materials today bio Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗